Cost-Effectively Deploying Edge Computing Technologies to Convenience Stores

 

When you think of the challenges that a convenience store owner or operator faces, bleeding-edge technology may not seem high on the priority list. Traditionally, the convenience store industry is conservative in its approach to early technology adoption due to slim margins and aggressive competition.

But challenges during the coronavirus have brought technology, innovation, and smart business solutions to the forefront of store owners’ minds, according to Intel IoT Sales Specialist Kristen Call and IoT Marketing Manager John Klafin.

Call and Klafin joined host Shelby Skrhak on this episode of To the Edge and Beyond to discuss edge technology deployment in the convenience store industry.

“I would have agreed, a year ago, that bleeding-edge technology is not on the forefront, but this last year has shifted that,” Call said.” We’re seeing a lot more of the industry dive into how to make their businesses smarter.”

Smart businesses have smart devices.

“We’ve seen the proliferation of edge computing, computer vision and artificial intelligence in the retail industry, as well as Internet of Things, where we make devices smart and connected,” Klafin said. “There’s a tremendous amount of intelligence that we’re helping retailers process and turn into valuable business insights.”

Actionable intelligence requires huge amounts of data, and data from internet-connected smart devices requires bandwidth to keep pace. Rather than connecting a store’s growing number of smart devices and sending all its respective data to the cloud, the edge platform can give stores the power to analyze data on-site.

More than making c-stores better with data and business insights, IoT is making stores safer during the COVID-19 pandemic. Contactless temperature checks for customers, density monitoring, and customer counting are all tools that store owners can use to keep their employees and customers safe.

“Having artificial intelligence as part of your game plan is a huge advantage,” Call said.

Learn more about deploying the edge in convenience stores by connecting with Kristen Call and John Klafin on LinkedIn or visit www.intel.com/retailSubscribe to this channel on Apple Podcasts, Spotify, or Google Podcasts to hear more from the Intel Internet of Things Group.

Follow us on social media for the latest updates in B2B!

Twitter – @MarketScale
Facebook – facebook.com/marketscale
LinkedIn – linkedin.com/company/marketscale

Follow us on social media for the latest updates in B2B!

Image

Latest

ESA
ESA Success Requires Strategy, Infrastructure, and Support Beyond Legislation
April 21, 2025

As education savings accounts (ESAs) gain traction across the United States, the conversation is shifting from policy debates to the complexities of implementation. Fueled by post-pandemic dissatisfaction with traditional school models and a desire for more customizable educational options, ESAs are being adopted in a growing number of states, often under “universal” frameworks. But…

Read More
supply chain data analytics
Supply Chain Data Analytics Fails Without Clean Data, Ventagium Delivers the Fix
April 21, 2025

Supply chain leaders face an overwhelming volume of siloed data across ERPs, TMS platforms, and warehouse systems, yet few know how to align it for smarter decisions. The stakes are rising fast. According to Capgemini’s 2024 report Data: A Powerful Ally in Tackling Scope 3 Emission Reduction Targets, 85% of organizations cite data access…

Read More
cancer immunotherapy
What’s Next in Preclinical Cancer Immunotherapy Research?
April 19, 2025

As the field of cancer immunotherapy rapidly evolves, researchers are turning to next-generation in vitro technologies to replicate the complexities of the tumor microenvironment with unprecedented fidelity. Organoid platforms and ex vivo patient-derived tissue models are transforming how scientists approach preclinical testing, offering deeper mechanistic insights and better predictive power for therapeutic response. With immunotherapies…

Read More
vitro
Analyzing the Suppressive TME in In Vitro Based Assays
April 19, 2025

In the rapidly advancing field of cancer immunotherapy, accurately modeling the tumor microenvironment (TME) has become essential to improving the predictive power of preclinical drug testing. As immune-modulating therapies surge forward, with over 4,000 immune modulators in development globally, scientists are refining assay technologies that maintain the complexity of patient-specific tumor biology. In vitro platforms…

Read More